Abiopharma

Lawsuit and motion for its approval as a class action against a subsidiary regarding the rate of insurance premiums

Form 144-NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144

Immediate Report of Meeting

NETGEAR Unleashes the AV Platform Layer with Launch of Align

JCDecaux : Disclosure of transactions in own shares

JCDecaux : Déclaration des transactions sur actions propres

NEURONES: Declaration of transactions on treasury shares (June 8 to 12, 2026)

NEURONES : Déclaration des transactions sur actions propres (période du 8 au 12 juin 2026)

Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy

Correction: Ekstraordinære indfrielser (CK 93)